REHILGO

Class [005]
Pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of pneumonia; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for the treatment of influenza; pharmaceutical preparations for the treatment of Hereditary Angioedema (HAE); pharmaceutical preparations for the treatment of acute respiratory distress syndrome (ARDS), Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Diseases (ILD); monoclonal antibodies for medical purposes; blood products namely pharmaceutical preparations for the treatment of hemophilia, drug preparations to aid in blood clotting;